Antarox P-104 is a EO/PO block copolymer, versatile, low foaming, dispersant for agrochemical formulations.
Antarox P-104 has high cloud point.
Antarox P-104 is a non-ionic surfactant that provides a versatile, low-foaming, dispersant for agrochemical formulations in crop protection.
CAS Number: 9003-11-6 ; 7732-18-5
Chemical Name: EO/PO Block Copolymer
Antarox P-104, is a non-ionic surfactant that provides a versatile, low-foaming, dispersant for agrochemical formulations in crop protection.
Antarox P-104 is an EO/PO block copolymer liquid that comes in IBC, drum, and bulk sizes.
Agent Name:
Poloxamers
CAS Number:
106392-12-5
Formula:
(C2-H4-O.C3-H6-O)x-
Major Category of Antarox P-104:
Plastics & Rubber
Poloxamers formula graphical representation
Category:
Polymers
Description:
Liquids, pastes, or solids.
Sources/Uses of Antarox P-104:
Antarox P-104 is a non-ionic surfactants with molecular weights ranging from 1,000 to greater than 16,000.
Antarox P-104 is used as food & drug additives, defoamers, anti-static agents, demulsifiers, detergents, wetting agents, gelling agents, emulsifiers, dispersants, and dye levelers.
Antarox P-104 is permitted for use as an inert ingredient in non-food pesticide products.
Synonyms:
High HLB nonionic emulsifier dispersant
Chemical category:
Water soluble polymers
Chemical family:
Synthetic Polymers
Chemical product:
Block Polymers
Additional Information of Antarox P-104:
Industries:
Active, Agricultural
Chemical Qualification:
EO/PO block copolymer, Nonionic
Antarox P-104 is a non-ionic surfactant that provides a versatile, low-foaming, dispersant for agrochemical formulations in crop protection.
KEYWORDS:
9003-11-6, 7732-18-5, EO/PO Block Copolymer, Antarox 17R4, Antarox 25R2, Antarox B 25, Antarox F 108, Antarox F 68, Antarox F 88, Antarox F 88FL
Information about Poloxamers:
Poloxamers are nonionic triblock copolymers composed of a central hydrophobic chain of polyoxypropylene (poly(propylene oxide)) flanked by two hydrophilic chains of polyoxyethylene (poly(ethylene oxide)).
The word poloxamer was coined by the inventor, Irving Schmolka, who received the patent for these materials in 1973.
Poloxamers are also known by the trade names Synperonics, Pluronic, and Kolliphor.
Because the lengths of the polymer blocks can be customized, many different poloxamers exist that have slightly different properties.
For the generic term poloxamer, these copolymers are commonly named with the letter P (for poloxamer) followed by three digits: the first two digits multiplied by 100 give the approximate molecular mass of the polyoxypropylene core, and the last digit multiplied by 10 gives the percentage polyoxyethylene content (e.g. P407 = poloxamer with a polyoxypropylene molecular mass of 4000 g/mo} and a 70% polyoxyethylene content).
For the Pluronic and Synperonic tradenames, coding of these copolymers starts with a letter to define its physical form at room temperature (L = liquid, P = paste, F = flake (solid)) followed by two or three digits.
The first digit (two digits in a three-digit number) in the numerical designation, multiplied by 300, indicates the approximate molecular weight of the hydrophobe; and the last digit x 10 gives the percentage polyoxyethylene content (e.g., L61 indicates a polyoxypropylene molecular mass of 1800 g/mol and a 10% polyoxyethylene content).
In the example given, poloxamer 181 (P181) = Pluronic L61 and Synperonic PE/L 61.
An important characteristic of poloxamer solutions is their temperature dependent self-assembling and thermo-gelling behavior.
Concentrated aqueous solutions of poloxamers are liquid at low temperature and form a gel at higher temperature in a reversible process.
The transitions that occur in these systems depend on the polymer composition (molecular weight and hydrophilic/hydrophobic molar ratio).
The phase transitions can also be largely influenced by the use of additives such as salts and alcohols.
The interactions with salts are related to their ability to act as water structure makers (salting-out) or water structure breakers (salting-in).
Salting-out salts increase the self-hydration of water through hydrogen bonding and reduce the hydration of the copolymers, thus reducing the critical micelle temperature and critical micelle concentration.
Salting-in electrolytes reduce the water self-hydration and increase the polymer hydration, therefore increasing the critical micelle temperature and critical micelle concentration.
The different salts have been categorized by the Hofmeister series according to their ‘salting-out’ power.
Different phase diagrams characterizing all these transitions have been constructed for most poloxamers using a great variety of experimental techniques (e.g. SAXS, Differential scanning calorimetry, viscosity measurements, light scattering).In bioprocess applications, poloxamers are used in cell culture media for their cell cushioning effects because their addition leads to less stressful shear conditions for cells in reactors.
In materials science, the poloxamer P123 has recently been used in the synthesis of mesoporous materials, including SBA-15.
When mixed with water, concentrated solutions of poloxamers can form hydrogels.
These gels can be extruded easily, acting as a carrier for other particles, and used for robocasting.
Work led by Kabanov has recently shown that some of these polymers, originally thought to be inert carrier molecules, have a very real effect on biological systems independently of the drug they are transporting.
The poloxamers have been shown to incorporate into cellular membranes affecting the microviscosity of the membranes.
The polymers seem to have the greatest effect when absorbed by the cell as an unimer rather than as a micelle.
Poloxamers have been shown to preferentially target cancer cells, due to differences in the membrane of these cells when compared to noncancer cells.
Poloxamers have also been shown to inhibit MDR proteins and other drug efflux transporters on the surface of cancer cells; the MDR proteins are responsible for the efflux of drugs from the cells and hence increase the susceptibility of cancer cells to chemotherapeutic agents such as doxorubicin.
The poloxamers have also been shown to enhance proto-apoptotic signaling, decrease anti-apoptoic defense in MDR cells, inhibit the glutathione/glutathione S-transferase detoxification system, induce the release of cytochrome C, increase reactive oxygen species in the cytoplasm, and abolish drug sequestering within cytoplasmic vesicles.
Certain poloxamers such as P85 have been shown not only to be able to transport target genes to target cells, but also to increase gene expression.
Certain poloxamers, such as P85 and L61, have also been shown to stimulate transcription of NF kappaB genes, although the mechanism by which this is achieved is currently unknown, bar that P85 has been shown to induce phosphorylation of the inhibitory kappa.
Wang et al. reported that aqueous solutions of poloxamer 188 (Pluronic F-68) and poloxamer 407 (Pluronic F-127) sonicated in the presence or absence of multi-walled carbon nanotubes (MWNTs) can became highly toxic to cultured cells.
Moreover, toxicity correlated with the sonolytic degradation of the polymers.
Poloxamer 407 is a hydrophilic non-ionic surfactant of the more general class of copolymers known as poloxamers.
Poloxamer 407 is a triblock copolymer consisting of a central hydrophobic block of polypropylene glycol flanked by two hydrophilic blocks of polyethylene glycol (PEG).
The approximate lengths of the two PEG blocks is 101 repeat units, while the approximate length of the propylene glycol block is 56 repeat units.
This particular compound is also known by trade name Pluronic F-127 or by the trade name Synperonic PE/F 127.
Most of the common uses of poloxamer 407 are related to its surfactant properties.
For example, it is widely used in cosmetics for dissolving oily ingredients in water.
It can also be found in multi-purpose contact lens cleaning solutions, where its purpose there is to help remove lipid films from the lens.
It can also be found in some mouthwashes.
There is a research ongoing for using poloxamer 407 for aligning severed blood vessels before gluing them surgically.
Poloxamer 407 is used in bioprinting applications due to its unique phase-change properties.
In a 30% solution by weight, poloxamer 407 forms a gel solid at room temperature but liquifies when chilled to 4 °C (39 °F).
This allows poloxamer 407 to serve as a removable support material, particularly for creating hollow channels or cavities inside hydrogels.
In this role, it is often referred to as a "sacrificial ink" or a "fugitive ink".
They gave a high dose (1 gram per kilogram of body weight) of poloxamer 407 to mice, which blocked 80% of the pores in liver cells that absorb lipoproteins, leading to a 10-fold increase in plasma lipid levels.
Wang et al. reported that aqueous solutions of poloxamer 188 and poloxamer 407 sonicated in the presence or absence of multi-walled carbon nanotubes (MWNTs) can become highly toxic to cultured cells.
The toxicity correlated with the sonolytic degradation of the polymers.
Poloxamers are nonionic triblock copolymers composed of a central hydrophobic chain of polyoxypropylene flanked by two hydrophilic chains of polyoxyethylene.
The word ‘poloxamer’ was coined by the inventor, Irving Schmolka, who received the patent for these materials in 1973.
Poloxamers are also known by their trade name Pluronics”.
Concentrated poloxamer solutions in water undergo thermoreversible sol–gel transition by the micellar mechanism.
Thermosensitive sol–gels of the commercial poloxamer 407 (Pluronic F127) have been suggested for use in short-term treatments such as pain management, infection treatment, fertility control, and in topical drug delivery.
Poloxamers are another type of thermo–sensitive hydrogels with an ABA–type triblock structure.
Poloxamer 407 (Pluronic F127, PEO99–PPO67–PEO99) is widely employed for drug delivery because it is reported to be non–toxic and can form gels at 25°C at a concentration of 20 wt%.
Like PNIPAAm polymers, much effort has been made to synthesize chemically crosslinkable poloxamers to equip them with enhanced mechanical properties.
Solutions of poloxamer 407 (∼25%) are viscous liquids below 25 °C; at body temperature they form a semisolid gel.
Weak mechanic strength, relatively high solubility in body fluids, and nonbiodegradability are the main hurdles for the use of poloxamer 407 in cell delivery systems.
Introduction of the carbonate linkage between poloxamer ‘blocks’ and linking of poloxamers into structures of a higher molecular mass118 were attempted to overcome these disadvantages.
However, only more sophisticated synthetic procedures offering graft copolymers hold promise for the application as injectable cell carriers.
While the physically crosslinked gels display a compressive modulus of 142.5 ± 29.7 KPa, radically crosslinked gels using the methacrylated poloxamer and ammonium persulfate (APS) as a thermal initiator are three times stiffer, displaying a compressive modulus of 415 ± 45.7 KPa.
Lysozyme has been utilized as a model protein to test the protein release profile of the diacrylated poloxamer hydrogels with higher mechanical properties.
These poloxamers instantaneously formed a semi–solidified physical gel when the temperature was increased above the LCST.
Then these poloxamers underwent photocrosslinking initiated by pre–mixed (4–Benzoylbenzyl)trimethylammonium chloride with UV exposure.
Since the middle block is hydrophobic and the two end blocks are hydrophilic, the poloxamer behaves as polymer surfactant.
It is used as nonionic polymer surfactant. They can function as antifoaming agents, wetting agents, dispersants, thickeners, and emulsifiers.
Poloxamers are triblock copolymers of poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO) available in different molecular weights and PPO/PEO ratios.
Another important property of Poloxamers is their thermogelling behaviour: in fact, water dispersions of some of these polymers are generally in the liquid phase at low temperatures but become a strong gel at increased temperatures.
It is for this reason that the Poloxamer 407 phase transitions and the effect of hydroxypropyl β-cyclodextrin (HP β–CD) on them were studied using acoustic spectroscopy with purpose of verifying the relevance of this method in the pharmaceutical field.
These works introduced here are just a small fraction of a large number of studies on poloxamers.
One of the reasons why poloxamers have been investigated by SANS is its variety of phase behavior, applications, particularly to bioengineering field.
Since there are many variations in poloxamer with different numbers of x, y, and z in spite of its simple structure, there still remain a large number of studies on poloxamer with SANS.
As the first step, the hydrodynamic diameter of the micelles of Poloxamer 407 in the concentration range of 3–25% (w/v) was investigated by measuring the attenuation and propagation velocity of ultrasound at different temperatures.
Then the effect of the addition of HP β-CD on the Poloxamer 407 water systems was monitored by adding different amounts [5–20% (w/v)] of HP β–CD, which is widely used in oral and parenteral pharmaceutical dosage forms since it increases the stability and solubility or poorly water-soluble drugs through the formation of inclusion complexes.
Previous studies had demonstrated that the addition of different glycols and polyalcohols, as well as the addition of HP β–CD, influenced both the gelation and micellization temperature of Poloxamer 407, outlining a shift of this parameter towards higher values.
In this case, acoustic spectroscopy allowed a better characterization of the microstructure and behaviour of these systems at increasing temperatures.
The positive thermoresponsive materials turn to gel above the upper critical solution temperature (USCT), which depends on the polymer structure, such as poloxamer, hydroxypropylcellulose, or methylcellulose.
The value of modulus G′ for Poloxamer 407 decreases during micellization until it reaches a plateau.
This trend is more evident in concentrated systems, but is practically not detectable for the dilute ones.
For the 17.5% and 20% samples, it is also possible to identify a slight inflexion after the plateau, which may be identified with the sol/gel transition since the corresponding values of the temperature are in agreement with those determined rheologically and by thermal analysis.
The poloxamers, also known by the trademark Pluronic, Synperonic and Tetronic, were initially introduced between 1950 and have presented several pharmaceutical applications, as well as, excellent compatibility with other compounds.
Studies showed some of the poloxamer’s characteristics, especially thermoresponsiveness, high capacity to solubilize drugs, good drug release characteristics, and absence of toxicity in mucosal membranes, and thus widely recognized in the pharmaceutical area as a safe material.
Poloxamers are nonionic compounds that contains a large group of copolymers surfactants formed by chains of ethylene oxide block (EO) and propylene oxide.
The poloxamer 407 or Pluronic F127 has particularly interest because of the thermoreversible properties, and can be useful in the optimization of drug delivery systems, and employed in many formulations like intravenous preparations, topical, ophthalmic, nasal, vaginal, and rectal, with no irritation or skin sensitivity.
Poloxamer 407 aqueous solutions have the property of being a thermoresponsive system, which leads to a sol–gel transition due to temperature increase.
The advantages of poloxamers in liquid pharmaceutical forms are especially because that they allow a comfortable release at the action site, gelling at the site and may have modified release.
Aqueous solutions of Poloxamer or Pluronic undergo sol-to-gel transition as the temperature increases.
However, the implanted gel of Poloxamer is quickly eroded and does not persist for more than a few days at most.
To improve the system, end-group modified Poloxamers, and multiblock co-polymers consisting of Poloxamer and biodegradable polymers have been developed.
In addition, random multiblock copolymers consisting of PEG, PPG, and a biodegradable polymer were reported.
Even though modification of the hydroxyl end groups of Poloxamer by oligolactides (LA6) and oligocaprolactones (CL6) increases hydrophobicity of the polymer, the sol-to-gel transition temperature and critical gel concentration increased, compared with the unmodified Poloxamer.
Poloxamer aqueous solution is driven by the unimer-to-micelle transition, followed by packing of the micelles.
The oligolactide and oligocaprolactone partition into the PPG micelle core and disturb the integrity and density of the original micelles of the unmodified Poloxamer.
Poloxamer. Thus, the micelle packing mechanism for the sol-to-gel transition is interfered with.
Poloxamer (F127) was modified by oligolactide (LA8 or LA18), and was then reacted with succinic anhydrides to prepare a carboxylic acid end-capped Poloxamer.
The polymer showed sol-gel transition in a pH/temperature dependent manner.
The ionization of carboxylic acid and the decrease in solubility of PEG at high pH were suggested to explain the phase behavior.
34,35 L-dihydroxyphenyalanine end-capped Poloxamer (F127) showed an increase in bioadhesion between the polymer and bovine mucin, an increase in the sol-to-gel transition temperature.
Multiblock copolymers were prepared to improve gel properties such as gel duration and biodegradation.
Poloxamers (F127) were coupled by hexa-methylene diisocyanate to prepare multiblock Poloxamer.
The drug release rate from the multiblock Poloxamer hydrogel was slower than from the unmodified Poloxamer hydrogel.
PEG/PPG alternating multiblock copolymers showing thermogelling were reported.Poloxamer was coupled by terephthalic anhydride to introduce the biodegradability as well as pH sensitivity.
Poloxamer was also coupled by disulfide to show glutathione sensitive degradation and drug release.
In addition, Poloxamer was end capped by l-oligolactide or d-oligolactide, then coupled to prepare the multiblock Poloxamer containing PLA.
By mixing the l-isomer and d-isomer containing multiblock Poloxamer, a stereocomplex showing thermal gelation was prepared.
Pluronics, also known as poloxamers, are a class of synthetic block copolymers which consist of hydrophilic poly(ethylene oxide) (PEO) and hydrophobic poly(propylene oxide) (PPO), arranged in an A-B-A triblock structure, thus giving PEO-PPO-PEO.
Poloxamer 407 in conjuction with HPMC has been used for rectal delivery of quinine in children.
Use of poloxamer 188 as a membrane sealant on in vitro studies of cardiac myocytes showed signs of possible prevention of cardiomyopathy and heart failure in muscular dystrophy.
A combination of poloxamer 407, poloxamer 188 and carbopol was utilized as an ophthalmic delivery system for puerarin, thus providing an alternative for longer-lasting drug availability to the precorneal area.
Poloxamer 407 has also shown prolonged duration of the painkiller, lidocaine, at the injection site as well as sustained drug release and increased therapeutic efficacy.
In the absence of interfering compounds, polymers of the poloxamer type can sometimes be determined by reversed-phase HPLC with methanol, but the most common separation technique is SEC.
There are many commercialized copolymers, such as Pluronics, Poloxamers, and Tetronics, which are comprised of PEO–PPO sequences.
Poloxamers, nonionic polymers polyoxyethylene–polyoxypropylene–polyoxyethylene (PEOn–PPOn–PEOn), are commonly used in pharmaceutical application in drug delivery.
Synonyms:
Poloxamer
Adeka 25R1
Adeka 25R2
Adeka L 61
Adeka Pluronic F 108
Antarox 17R4
Antarox 25R2
Antarox B 25
Antarox F 108
Antarox F 68
Antarox F 88
Antarox F 88FL
Antarox L 61
Antarox L 72
Antarox P 104
Antarox P 84
Antarox SC 138
Arco Polyol R 2633
Arcol E 351
B 053
BASF-L 101
Block polyethylene-polypropylene glycol
Block polyoxyethylene-polyoxypropylene
Breox BL 19-10
CRL 1005
CRL 1605
CRL 8131
CRL 8142
Cirrasol ALN-WS
Crisvon Assistor SD 14
D 500 (polyglycol)
Daltocel F 460
Dehypon KE 3557
Detalan
Empilan P 7068
Emulgen PP 230
Epan 450
Epan 485
Epan 710
Epan 785
Epan U 108
Ethylene glycol-propylene glycol block copolymer
Ethylene oxide-propylene oxide block copolymer dipropylene glycol ether
Ethylene oxide-propylene oxide block copolymer ether with ethylene glycol
Ethylene oxide-propylene oxide block polymer
F 108
F 127
F 77
F 87
F 88
Lutrol F
Methyloxirane polymer with oxirane block
P 103
P 104
P 105
P 123
P 65
P 84
P 85
Pluracare
Pluronic
Pluronic L 61
Poloxamer 188
Polyoxamer 108
Polyoxypropylene-polyoxyethylene block copolymer
Propylene oxide ethylene oxide block polymer
Slovanik M-640
Tergitol nonionic XH
alpha-Hydro-omega-hydroxypoly(oxyethylene)(sub a)-poly(oxopropylene)(sub b)-poly(oxyethylene)(sub a) block copolymer
Oxirane, methyl-, polymer with oxirane
Oxirane, methyl-, polymer with oxirane, block
Pluronic F 38
Pluronic F108
Pluronic F127
Pluronic F68
Pluronic F77
Pluronic F87
Pluronic F88
Pluronic L-81
Pluronic L44
Pluronic L62
Pluronic L64
Pluronic P103
Pluronic P104
Pluronic P105
Pluronic P123
Pluronic P65
Pluronic P84
Pluronic P85
Poloxamer-188
Tergitol XH
alpha-Hydro-omega-hydroxypoly(oxyethylene)a-poly(oxopropylene)b-poly(oxyethylene)a block copolymer
.alpha.-Hydro-.omega.-hydroxypoly(oxyethylene) poly(oxypropylene) po ly(oxyethylene) block copolymer
1,2-Propyleneglycol, Ethoxylated And Propoxylated
75-H-1400
75H90000
Adeka 25R1
Adeka 25R2
Adeka L 61
Adeka Pluronic F 108
alpha-Hydro-omega-hydroxypoly(oxyethylene) (sub a)-poly(oxopropylene) (sub b)-poly(oxyethylene) (sub a) block copolymer
alpha-Hydro-omega-hydroxypoly(oxyethylene) a-poly(oxopropylene) b-poly(oxyethylene) a block copolymer
Antarox 17R4
Antarox 25R2
Antarox B 25
Antarox F 108
Antarox F 68
Antarox F 88
Antarox F 88FL
Antarox L 61
Antarox L 72
Antarox P 104
Antarox P 84
Antarox SC 138
Arco Polyol R 2633
Arcol E 351
B 053
BASF-L 101
Berol TVM 370
Block polyethylene-polypropylene glycol
Block polyoxyethylene-polyoxypropylene
Breox BL 19-10
BSP 5000
Cirrasol ALN-WS
Crisvon Assistor SD 14
Crl 1005
CRL 1605
CRL 8131
CRL 8142
D 500 (polyglycol)
D01941
Daltocel F 460
Dehypon KE 3557
Detalan
Eban 710
Emkalyx EP 64
Emkalyx L 101
Emkalyx L101
Empilan P 7068
Emulgen PP 230
Epan 450
Epan 485
Epan 710
Epan 750
Epan 785
Epan U 108
Epon 420
Ethylene glycol-propylene glycol block copolymer
Ethylene glycol-propylene glycol polymer
ETHYLENE OXIDE, PROPYLENE OXIDE BLOCK POLYMER
Ethylene oxide-propylene oxide block copolymer dipropylene glycol ether
Ethylene oxide-propylene oxide block copolymer ether with ethylene glycol
Ethylene oxide-propylene oxide block polymer
Ethylene oxide-propylene oxide copolymer
F 108
F 127
F 77
F 87
F 88
F-108
Genapol PF 10
Glycols, polyethylene-polypropylene
Glycols, polyethylenepolypropylene
Hydrowet
Laprol 1502
LG 56
Lutrol F
Lutrol F (TN)
M 90/20
Magcyl
Meroxapol 105
Methyloxirane polymer with oxirane block
Methyloxirane-oxirane copolymer
Methyloxirane-oxirane polymer
Monolan 8000E80
Monolan PB
N 480
Newpol PE-88
Niax 16-46
Niax LG 56
Nissan Pronon 201
Nixolen SL 19
Oligoether L-1502-2-30
Oxirane, methyl-, polymer with oxirane
Oxirane, methyl-, polymer with oxirane, block
Oxirane, methyl-, polymer with oxirane, ether with 1,2-propanediol (2:1)
Oxirane, polymer with methyloxirane
Oxirane-methyloxirane polymer
P 103
P 104
P 105
P 123
P 65
P 84
P 85
PEG/PPG-125/30 Copolymer
Plonon 201
Plonon 204
Pluracare
Pluracol V
Pluriol PE
Pluriol PE 6810
Pluronic
Pluronic 10R8
Pluronic 31R2
Pluronic C 121
Pluronic F
Pluronic F 108
Pluronic F 125
Pluronic F 127
Pluronic F 38
Pluronic F 68
Pluronic F 68LF
Pluronic F 87
Pluronic F 88
Pluronic F 98
Pluronic F-68
Pluronic F108
Pluronic F127
Pluronic F68
Pluronic F77
Pluronic F86
Pluronic F87
Pluronic F87-A7850
Pluronic F88
Pluronic L
Pluronic L 101
Pluronic L 121
Pluronic L 122
Pluronic L 24
Pluronic L 31
Pluronic L 35
Pluronic L 44
Pluronic L 61
Pluronic L 62
Pluronic L 64
Pluronic L 68
Pluronic L 92
Pluronic L-101
Pluronic L-81
Pluronic L44
Pluronic L62
Pluronic l62 (mw 2500)
Pluronic L64
Pluronic l64 (mw 2900)
Pluronic P
Pluronic P 104
Pluronic P 75
Pluronic P 85
Pluronic P-65
Pluronic P-75
Pluronic P103
Pluronic P104
Pluronic P105
Pluronic P123
Pluronic P65
Pluronic P84
Pluronic P85
Pluronic-68
Poloxalene
Poloxalene L64
Poloxalene [USAN:BAN:INN]
Poloxalkol
POLOXAMER
Poloxamer (NF)
Poloxamer 101
Poloxamer 108
Poloxamer 182LF
Poloxamer 188
Poloxamer 331
Poloxamer 407
Poloxamer [USAN:BAN:INN]
Poloxamer-188
Poly (propylene oxide-ethylene oxide)
Poly(ethylene oxide-co-propylene oxide)
Poly(mixed ethylene, propylene) glycol
Poly(oxyethylene)-poly(oxypropylene) glycol
Poly(oxyethylene)-poly(oxypropylene) polymer
Polyethylene glycol, propoxylated
Polyethylene oxide-polypropylene oxide
Polyethylene oxide-polypropylene oxide copolymer
Polyethylene-Pluronic L-62LF
Polyethylene-polypropylene glycol
Polykol
Polylon 13-5
Polyoxamer 108
Polyoxyethylenated poly (oxypropylene)
Polyoxyethylene - polyoxypropylene block copolymer
Polyoxyethylene - polyoxypropylene copolymer
Polyoxyethylene polyoxypropylene
Polyoxyethylene-oxy-propylene [French]
Polyoxyethylene-polyoxypropylene
Polyoxyethylene-polyoxypropylene polymer
Polyoxypropylene-polyoxyethylene block copolymer
Polypropoxylated, polyethoxylated propylene glycol
Polypropylene glycol, ethoxylated
Polypropylene glycol-ethylene oxide copolymer
PPG Diol 3000EO
Proksanol
Pronon
Pronon 102
Pronon 104
Pronon 201
Pronon 204
Pronon 208
Propane-1,2-diol, ethoxylated, propoxylated
Propylen M 12
Propylene glycol, propylene oxide, ethylene oxide polymer
Propylene oxide-ethylene oxide copolymer
Propylene oxide-ethylene oxide polymer
Proxanol
Proxanol 158
Proxanol 228
Proxanol Tsl-3
RC 102
Regulaid
Rokopol 16P
Rokopol 30P
Rokopol 30P9
SK and F 18,667
SK&F 18,667
SKandF 18,667
Slovanik
Slovanik 630
Slovanik 660
Slovanik M-640
Supronic B 75
Supronic E 400
Synperonic PE 30/40
Tergitol monionic XH
Tergitol nonionic XH
Tergitol XH
Tergitol XH (nonionic)
Teric PE 61
Teric PE 62
Teric PE40
Teric PE60
Teric PE70
Thanol E 4003
Therabloat
TsL 431
TVM 370
Unilube 50MB168X
Unilube 50MB26X
Velvetol OE 2NT1
Voranol P 2001
WS 661
Wyandotte 7135